Fundamentals and Future Trends of 3D Printing in Drug Delivery - Tapa blanda

Acerca de los autores

Professor Dimitrios A. Lamprou (Ph.D. MBA) is the Chair of Biofabrication and Advanced Manufacturing, the Director of Internationalisation, and the Director at MSc Industrial Pharmaceutics at Queen's University Belfast. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS) and Visiting Professor in several International Institutions. Dimitrios, is the author of more than 170 peer-reviewed publications, has over 450 conference abstracts, and has given over 200 Invited Talks in institutions and conferences across the world. Dimitrios, has also been named in the Stanford University's list of World's Top 2% Scientists, for several consecutive years, for his research in Pharmaceutics and Biomedical Engineering.

Dimitris Fatouros is Professor in Pharmaceutics at Aristotle University of Thessaloniki School of Pharmacy. He holds a PhD in Pharmaceutical Technology from the School of Pharmacy at the University of Patras in Greece. He subsequently held posts as a Post-Doctoral fellow at Leiden/Amsterdam Centre of Drug Delivery (LA/CDR), Research Assistant Professor at Danish University of Pharmaceutical Sciences and Senior Lecturer at School of Pharmacy and Biomedical Portsmouth University. His areas of research expertise cover additive manufacturing, mucosal delivery, nanomedicine and poorly soluble drugs. He has contributed over 180 publications in refereed journals and books. He has filled three national (granted) and five international patents. He has been Theme Editor in Advanced Drug Delivery Reviews “Personalized nanomedicine” (Editors, Vizirianakis and Fatouros, ADDR 2012 64 :1359-62) and “Additive Manufacturing in Pharmaceutical Product Design” (Editors, Rantanen and Fatouros 2021 178:113991). He is Associate Editor in Journal of Drug Delivery Science and Technology (Elsevier), Associate Editor in Frontiers and Bioengineering and Biotechnology and member of the Editorial Board of Pharmaceutics.